US FDA approves first oral tablet called baricitinib for treatment of alopecia - WION

Alopecia, which is an autoimmune disorder affecting more than 300,000 people in the United States every year, which leads to emotional distress and causes either temporary or permanent patchy hair loss that can affect any hair-bearing site of the body

In a first, the United States Food and Drug Administration has approved an oral tablet called baricitinib for the treatment of alopecia. Alopecia, which is an autoimmune disorder affecting more than… [+1718 chars]

full article...